TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Svea Vaccin AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
134,859
|
113,033
|
170,053 |
| Financial expenses |
38
|
0
|
30 |
| Earnings before taxes |
11,120
|
12,529
|
37,691 |
| EBITDA |
11,277
|
12,050
|
37,891 |
| Total assets |
31,050
|
24,900
|
48,269 |
| Current assets |
28,771
|
22,699
|
46,253 |
| Current liabilities |
18,083
|
13,875
|
18,052 |
| Equity capital |
11,785
|
10,364
|
30,217 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
91
|
65
|
80 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
38.0%
|
41.6%
|
62.6% |
| Turnover per employee |
1,482
|
1,739
|
2,126 |
| Profit as a percentage of turnover |
8.2%
|
11.1%
|
22.2% |
| Return on assets (ROA) |
35.9%
|
50.3%
|
78.1% |
| Current ratio |
159.1%
|
163.6%
|
256.2% |
| Return on equity (ROE) |
94.4%
|
120.9%
|
124.7% |
| Change turnover |
21,244
|
-43,245
|
90,767 |
| Change turnover % |
19%
|
-28%
|
114% |
| Chg. No. of employees |
26
|
-15
|
31 |
| Chg. No. of employees % |
40%
|
-19%
|
63% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.